Quest Diagnostics | DGX - Ebitda


Quest Diagnostics reported $627M in EBITDA for its fiscal quarter ending in September of 2026.





Ebitda Change Date
Acadia Healthcare USD 176.45M 27.26M Sep/2026
Agilent USD 577M 77M Jun/2026
Baxter International USD 474M 165M Jun/2026
Bruker USD 143.2M 33.2M Jun/2026
Cardinal Health USD 955M 135M Jun/2026
Centene USD 326M 1.22B Sep/2026
Charles River Laboratories USD 298.04M 25.1M Sep/2026
Cigna USD 3.27B 9M Jun/2026
Community Health Systems USD 395M 19M Dec/2025
CVS Health USD 4.9B 951M Sep/2026
Danaher USD 2.1B 257M Sep/2026
DaVita Healthcare Partners USD 664.44M 82.37M Sep/2026
Elevance Health USD 2.67B 1.54B Sep/2026
Encompass Health USD 346.6M 1.4M Sep/2026
HCA USD 3.92B 109M Sep/2026
Henry Schein USD 321M 33M Sep/2026
Humana USD 2.06B 2.35B Mar/2026
Illumina USD 330M 80M Jun/2026
IQVIA Holdings USD 1.03B 38M Sep/2026
Laboratory Of America USD 674.3M 93.4M Sep/2026
McKesson USD 1.97B 262M Sep/2026
Mettler Toledo International USD 322.64M 43.66M Jun/2026
Molina Healthcare USD 144M 53M Sep/2026
Owens Minor USD 90.02M 2.15M Dec/2025
Pediatrix Medical Group USD 65.84M 21.47M Dec/2025
Quest Diagnostics USD 627M 21M Sep/2026
Revvity USD 227.55M 629K Sep/2026
Tenet Healthcare USD 1.36B 51M Sep/2026
Thermo Fisher Scientific USD 3.79B 244M Sep/2026
UnitedHealth USD 9.43B 567M Jun/2026
Universal Health Services USD 624.64M 53.22M Sep/2026
Veradigm USD 38.81M 29.61M Sep/2022
Waters USD 554M 158M Sep/2026
Zoetis USD 1.05B 107M Jun/2026